Why choose Bionet
BIONETCorp. was established in 1999.
Serves more than 50% of newborns and 88% of reproductive medicine centers in Taiwan
while expanding services to 17 countries oversea meeting the health needs of more than 1.4 million customers at different stages in life.
In 2007, BIONET successfully completed initial public offering (IPO).
BIONET has received matching inquiries through the database for more than one thousand times from
over 30 different countries and released more than 360 stem cell units for cellular therapies throughout the world.
Key Services and Offerings
1. Customized Exosome Services(My Exosome): Amniotic fluid exosome(AF exosome), Cord blood exosome(CB exosome), Platelet-rich exosome(PRE), Mesenchymal stem cell-derived exosome.
2. Hematopoietic Stem Cell Storage and Applications: Cord blood and Adult peripheral blood stem cell banking.
3. Mesenchymal Stem Cell Storage and Applications: Cord tissue, Adipose tissue, and Dental pulp stem cell banking.
4. Immune Cell Storage and Applications: NK cell and CIK cell banking and therapies.
5. Non-Invasive Prenatal Chromosomal Testing (NIPT)
名人心得分享
一般存戶分享
一般存戶分享
醫護心得分享
New Era in Regenerative Medicine |
New Era in Regenerative Medicine
